Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13,077 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model.
Tran TA, Kim YH, Duong TH, Thangaraj J, Chu TH, Jung S, Kim IY, Moon KS, Kim YJ, Lee TK, Lee CW, Yun H, Lee JJ, Lee HJ, Lee KH, Jung TY. Tran TA, et al. Among authors: lee cw, lee tk, lee kh, lee jj, lee hj. Front Immunol. 2023 Jan 10;13:1009484. doi: 10.3389/fimmu.2022.1009484. eCollection 2022. Front Immunol. 2023. PMID: 36703992 Free PMC article.
Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists.
Nguyen-Pham TN, Lim MS, Nguyen TA, Lee YK, Jin CJ, Lee HJ, Hong CY, Ahn JS, Yang DH, Kim YK, Chung IJ, Park BC, Kim HJ, Lee JJ. Nguyen-Pham TN, et al. Among authors: lee jj, lee yk, lee hj. Cell Mol Immunol. 2011 Jul;8(4):341-7. doi: 10.1038/cmi.2011.7. Epub 2011 Mar 21. Cell Mol Immunol. 2011. PMID: 21423200 Free PMC article.
Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins.
Yang DH, Kim MH, Lee YK, Hong CY, Lee HJ, Nguyen-Pham TN, Bae SY, Ahn JS, Kim YK, Chung IJ, Kim HJ, Kalinski P, Lee JJ. Yang DH, et al. Among authors: lee jj, lee yk, lee hj. Ann Hematol. 2011 Dec;90(12):1419-26. doi: 10.1007/s00277-011-1219-y. Epub 2011 Apr 5. Ann Hematol. 2011. PMID: 21465188
Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer.
Park MH, Yang DH, Kim MH, Jang JH, Jang YY, Lee YK, Jin CJ, Pham TN, Thi TA, Lim MS, Lee HJ, Hong CY, Yoon JH, Lee JJ. Park MH, et al. Among authors: lee jj, lee yk, lee hj. Cancer Res Treat. 2011 Mar;43(1):56-66. doi: 10.4143/crt.2011.43.1.56. Epub 2011 Mar 31. Cancer Res Treat. 2011. PMID: 21509164 Free PMC article.
Induction of myeloma-specific cytotoxic T lymphocytes responses by natural killer cells stimulated-dendritic cells in patients with multiple myeloma.
Nguyen-Pham TN, Im CM, Nguyen TA, Lim MS, Hong CY, Kim MH, Lee HJ, Lee YK, Cho D, Ahn JS, Yang DH, Kim YK, Chung IJ, Kim HJ, Lee JJ. Nguyen-Pham TN, et al. Among authors: lee jj, lee hj, lee yk. Leuk Res. 2011 Sep;35(9):1241-7. doi: 10.1016/j.leukres.2011.03.032. Epub 2011 May 25. Leuk Res. 2011. PMID: 21612823
Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy.
Nguyen-Pham TN, Yang DH, Nguyen TA, Lim MS, Hong CY, Kim MH, Lee HJ, Lee YK, Cho D, Bae SY, Ahn JS, Kim YK, Chung IJ, Kim HJ, Lee JJ. Nguyen-Pham TN, et al. Among authors: lee jj, lee hj, lee yk. Cell Mol Immunol. 2012 Jan;9(1):45-53. doi: 10.1038/cmi.2011.23. Epub 2011 Aug 8. Cell Mol Immunol. 2012. PMID: 21822297 Free PMC article. Clinical Trial.
Cellular immunotherapy using dendritic cells against multiple myeloma.
Nguyen-Pham TN, Lee YK, Lee HJ, Kim MH, Yang DH, Kim HJ, Lee JJ. Nguyen-Pham TN, et al. Among authors: lee jj, lee yk, lee hj. Korean J Hematol. 2012 Mar;47(1):17-27. doi: 10.5045/kjh.2012.47.1.17. Epub 2012 Mar 28. Korean J Hematol. 2012. PMID: 22479274 Free PMC article.
Dendritic cells loaded with myeloma cells pretreated with a combination of JSI-124 and bortezomib generate potent myeloma-specific cytotoxic T lymphocytes in vitro.
Jung SH, Lee YK, Lee HJ, Choi NR, Vo MC, Hoang MD, Lim MS, Nguyen-Pham TN, Kim HJ, Lee JJ. Jung SH, et al. Among authors: lee jj, lee yk, lee hj. Exp Hematol. 2014 Apr;42(4):274-81. doi: 10.1016/j.exphem.2013.12.008. Epub 2014 Jan 7. Exp Hematol. 2014. PMID: 24407159 Free article. Clinical Trial.
13,077 results
You have reached the last available page of results. Please see the User Guide for more information.